Exposure to D11 leads to: i) down-regulation of EGFR expression levels, which may represent a clear advantage for the treatment of certain types of cancers carrying aberrant expression of this growth factor receptor and ii) inhibition of cell motility particularly important in the case of highly invasive cancer cells [16, 70]. Here, EGFR is linked to cancer.